Trial intelligence / Profile preview

Rabeprazole sodium injection for duodenal ulcer bleeding

CTR20130298Phase 2Completed

Sponsor
Yangtze River Pharmaceutical Group
Start
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of rabeprazole in duodenal ulcer, sponsored by Yangtze River Pharmaceutical Group. Started Mar 2014; status: completed.

02

Drugs

rabeprazole
03

Conditions

duodenal ulcer

Beyond the preview

Go deeper on CTR20130298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call